SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-24-028380
Filing Date
2024-05-31
Accepted
2024-05-31 16:30:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G ef20030320_sc13g.htm SC 13G 64012
  Complete submission text file 0001140361-24-028380.txt   65939
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Subject) CIK: 0002007919 (see all company filings)

IRS No.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94527 | Film No.: 241010265
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)